Inhibrx(INBX) - 2024 Q1 - Quarterly Results
Inhibrx(INBX)2024-05-09 20:08About Inhibrx, Inc. Inhibrx is a clinical-stage biopharmaceutical company focused on developing a broad pipeline of novel biologic therapeutic candidates in oncology and orphan diseases. Inhibrx utilizes diverse methods of protein engineering to address the specific requirements of complex target and disease biology, including its proprietary protein engineering platforms. For more information, please visit www.inhibrx.com. Exhibit 99.1 Inhibrx Reports First Quarter 2024 Financial Results and Recent Corpora ...